These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1464 related items for PubMed ID: 25879771

  • 1. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, Ren ZG.
    J Hematol Oncol; 2015 Mar 11; 8():23. PubMed ID: 25879771
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
    Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW.
    Cancer Res; 2010 Dec 15; 70(24):10433-44. PubMed ID: 21159654
    [Abstract] [Full Text] [Related]

  • 3. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW.
    Oncotarget; 2017 Apr 04; 8(14):23507-23516. PubMed ID: 28186991
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells.
    Liu L, Zhu H, Liao Y, Wu W, Liu L, Liu L, Wu Y, Sun F, Lin HW.
    Biomed Pharmacother; 2020 Jul 04; 127():110225. PubMed ID: 32428834
    [Abstract] [Full Text] [Related]

  • 5. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB, Yang DP, Wen XD, Chen XJ, Zhang L, Wu LL, Bie P, Xia F.
    J Exp Clin Cancer Res; 2017 Jun 24; 36(1):86. PubMed ID: 28646927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
    Yin X, Li YW, Zhang BH, Ren ZG, Qiu SJ, Yi Y, Fan J.
    Ann Surg Oncol; 2012 Sep 24; 19(9):2877-87. PubMed ID: 22461131
    [Abstract] [Full Text] [Related]

  • 8. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Snail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer.
    Liu CW, Li CH, Peng YJ, Cheng YW, Chen HW, Liao PL, Kang JJ, Yeng MH.
    Oncotarget; 2014 Jun 15; 5(11):3880-94. PubMed ID: 25003810
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL.
    Zhou ZJ, Dai Z, Zhou SL, Hu ZQ, Chen Q, Zhao YM, Shi YH, Gao Q, Wu WZ, Qiu SJ, Zhou J, Fan J.
    Cancer Res; 2014 May 15; 74(10):2750-62. PubMed ID: 24638979
    [Abstract] [Full Text] [Related]

  • 13. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
    Dang H, Ding W, Emerson D, Rountree CB.
    BMC Cancer; 2011 Sep 19; 11():396. PubMed ID: 21929801
    [Abstract] [Full Text] [Related]

  • 14. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 Sep 19; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

  • 15. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B, Liu T, Wu JC, Luo SZ, Chen R, Lu LG, Xu MY.
    Biomed Pharmacother; 2018 Feb 19; 98():214-221. PubMed ID: 29268242
    [Abstract] [Full Text] [Related]

  • 16. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.
    Yao C, Su L, Shan J, Zhu C, Liu L, Liu C, Xu Y, Yang Z, Bian X, Shao J, Li J, Lai M, Shen J, Qian C.
    Stem Cells; 2016 Apr 19; 34(4):820-31. PubMed ID: 26840943
    [Abstract] [Full Text] [Related]

  • 17. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q, Chen K, Liu Z, Huang Y, Zhao R, Wei L, Yu X, He J, Liu J, Qi J, Qin Y, Li B.
    Cancer Lett; 2017 Sep 10; 403():165-174. PubMed ID: 28645561
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
    Murakami S, Ninomiya W, Sakamoto E, Shibata T, Akiyama H, Tashiro F.
    Stem Cells; 2015 Sep 10; 33(9):2652-63. PubMed ID: 26013162
    [Abstract] [Full Text] [Related]

  • 20. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S, Sun J, Cai B, Xi X, Yang L, Zhang Z, Feng Y, Sun Y.
    Tumour Biol; 2016 Jul 10; 37(7):9671-80. PubMed ID: 26801672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.